blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3982986

EP3982986 - SECRETED MICROBIAL EXTRACELLULAR VESICLES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  18.03.2022
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  18.12.2020
Formerunknown
Status updated on  14.08.2020
Most recent event   Tooltip06.08.2024New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
[2022/16]
Inventor(s)01 / BALLOK, Alicia
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
02 / BODMER, Mark
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
03 / BOSE, Baundauna
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
04 / CARLTON, Sofia M.R.
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
05 / CORMACK, Taylor A.
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
06 / DAVITT, Christopher J. H.
3 Danforth Street Unit B
Jamaica Plain, Massachusetts 02130 / US
07 / FRANCISCO-ANDERSON, Loise
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
08 / GOODMAN, Brian
16 McBride Street 1
Jamaica Plain, MA 02130 / US
09 / ITANO, Andrea
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
10 / OKAN, Nihal
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
11 / PONICHTERA, Holly
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
12 / TROY, Erin B.
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
13 / ROMANO-CHERNAC, Fabian B.
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
14 / SIZOVA, Maria
c/o Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge, MA 02139 / US
 [2022/16]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2022/16]
Application number, filing date20751723.611.06.2020
[2022/16]
WO2020US37201
Priority number, dateUS201962860029P11.06.2019         Original published format: US 201962860029 P
US201962860049P11.06.2019         Original published format: US 201962860049 P
US202062979545P21.02.2020         Original published format: US 202062979545 P
US202062991767P19.03.2020         Original published format: US 202062991767 P
[2022/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020252144
Date:17.12.2020
Language:EN
[2020/51]
Type: A1 Application with search report 
No.:EP3982986
Date:20.04.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 17.12.2020 takes the place of the publication of the European patent application.
[2022/16]
Search report(s)International search report - published on:EP17.12.2020
ClassificationIPC:A61K35/74, A61K35/745, A61K35/744, A61P37/00, A61P35/00
[2022/16]
CPC:
A61K35/74 (EP,CN,KR,US); A61K35/745 (EP,CN,US); A61K35/744 (EP,CN,US);
A61K45/06 (US); A61K9/0053 (US); A61P29/00 (CN,KR);
A61P3/00 (CN,KR); A61P35/00 (EP,CN,KR,US); A61P37/00 (EP,CN,US);
A61P37/04 (CN,KR); A61P37/06 (CN,KR,US); A61K2035/115 (US);
Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/16]
TitleGerman:SEKRETIERTE MIKROBIELLE EXTRAZELLULÄRE VESIKEL[2022/16]
English:SECRETED MICROBIAL EXTRACELLULAR VESICLES[2022/16]
French:VÉSICULES EXTRACELLULAIRES MICROBIENNES SÉCRÉTÉES[2022/16]
Entry into regional phase22.12.2021National basic fee paid 
22.12.2021Designation fee(s) paid 
22.12.2021Examination fee paid 
Examination procedure22.12.2021Examination requested  [2022/16]
22.12.2021Date on which the examining division has become responsible
12.07.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
20.03.2022Renewal fee patent year 03
24.08.2023Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.06.202304   M06   Fee paid on   24.08.2023
30.06.202405   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]EP3403670  (MD HEALTHCARE INC [KR]) [X] 1-17,23-65,68-73,76 * paragraphs [0006] , [0011] , [0 17] , [0 42]; claims 1-11 * [I] 18-22,66,67,74,75;
 [XI]WO2019010255  (EVELO BIOSCIENCES INC [US]) [X] 1-17,23-65,68-73,76 * Examples; paragraph [0005]; claims 1-133 * [I] 18-22,66,67,74,75;
 [XI]WO2019051380  (EVELO BIOSCIENCES INC [US]) [X] 1-17,23-65,68-73,76 * Examples; paragraphs [0002] , [0081] , [0300] , [0332]; claims 1-161; table 1 * [I] 18-22,66,67,74,75;
 [XI]WO2019051381  (EVELO BIOSCIENCES INC [US]) [X] 1-17,23-65,68-73,76 * Examples;; claims 1-181 * [I] 18-22,66,67,74,75;
 [XI]WO2019099482  (EVELO BIOSCIENCES INC [US]) [X] 1-17,23-65,68-73,76 * Examples; paragraphs [0060] , [0061] , [0066] , [0 97] - [0100] - [0243]; claims 1-129 * [I] 18-22,66,67,74,75;
 [XI]WO2019099682  (EVELO BIOSCIENCES INC [US]) [X] 1-17,23-65,68-73,76 * Examples;; claims 1-94 * [I] 18-22,66,67,74,75;
 [XI]  - CHIL-SUNG KANG ET AL, "Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced Colitis", PLOS ONE, (20130101), vol. 8, no. 10, doi:10.1371/journal.pone.0076520, ISSN 1932-6203, pages e76520 - e76520, XP055106720 [X] 1,40,42,63,68 * abstract * * Introduction and Discussion * [I] 1-76

DOI:   http://dx.doi.org/10.1371/journal.pone.0076520
by applicant   - PEARSON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, page 2444
    - DEVEREUX, J. et al., Nucleic Acids Research, (19840000), vol. 12, no. I, page 387
    - S. F. et al., J Molec Biol, (19900000), vol. 215, page 403
    - CARILLO, SIAM J Applied Math, (19880000), vol. 48, page 1073
    - SCHOCH et al., "Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi", PNAS, (20120000), vol. 109, doi:10.1073/pnas.1117018109, pages 6241 - 6246, XP055194048

DOI:   http://dx.doi.org/10.1073/pnas.1117018109
    - Nucleic Acids Res, vol. 38, page e200
    - KONSTANTINIDIS KTRAMETTE ATIEDJE JM, "The bacterial species definition in the genomic era", Philos Trans R Soc Lond B Biol Sci, (20060000), vol. 361, pages 1929 - 1940
    - ACHTMAN MWAGNER M., "Microbial diversity and the genetic nature of microbial species", Nat. Rev. Microbiol., (20080000), vol. 6, doi:10.1038/nrmicro1872, pages 431 - 440, XP055597710

DOI:   http://dx.doi.org/10.1038/nrmicro1872
    - S. BIN PARK et al., PLoS ONE, (20110000), vol. 6, no. 3, page el7629
    - G. NORHEIM et al., PLoS ONE, (20150000), vol. 10, no. 9, page e0134353
    - JEPPESEN et al., Cell, (20190000), vol. 177, page 428
    - LEEKHA et al., "General Principles of Antimicrobial Therapy", Mayo Clin Proc., (20110000), vol. 86, no. 2, doi:10.4065/mcp.2010.0639, pages 156 - 167, XP055372896

DOI:   http://dx.doi.org/10.4065/mcp.2010.0639
    - WEISSTHIERRY, "Mechanisms and consequences of intestinal dysbiosis", Cellular and Molecular Life Sciences, (20170000), vol. 74, no. 16, doi:10.1007/s00018-017-2509-x, pages 2959 - 2977, XP036272294

DOI:   http://dx.doi.org/10.1007/s00018-017-2509-x
    - Zurich Open Repository and Archive, URL: https://doi.org/10.1007/s00018-017-2509-x
    - HOOKSO'MALLEY, Dysbiosis and its discontents, American Society for Microbiology, (20171000), vol. 8, pages e01492 - 17
    - CITI, S, "Intestinal Barriers protect against disease", Science, (20180000), vol. 359, pages 1098 - 99
    - SRINIVASAN et al., "TEER measurement techniques for in vitro barrier model systems", J. Lab. Autom., (20150000), vol. 20, doi:10.1177/2211068214561025, pages 107 - 126, XP055560328

DOI:   http://dx.doi.org/10.1177/2211068214561025
    - LYNCH et al., "The Human Microbiome in Health and Disease", N. Engl. J. Med ., (20160000), vol. 375, pages 2369 - 79
    - CARDING et al., "Dysbiosis of the gut microbiota in disease", Microb. Ecol. Health Dis., (20150000), vol. 26, page 10
    - LEVY et al., "Dysbiosis and the Immune System", Nature Reviews Immunology, (20170400), vol. 17, page 219
    - THEIN et al., "Efficient subfractionation of gram-negative bacteria for proteomics studies", J. Proteome Res., (20101203), vol. 9, no. 12, pages 6135 - 47
    - SANDRINI et al., "Fractionation by Ultracentrifugation of Gram negative cytoplasmic and membrane proteins", Bio-Protocol., (20140000), vol. 4, no. 21
    - BACHURSKI et al., Journal of Extracellular Vesicles, (20190000), vol. 8, no. 1
    - MALETZKI et al., Gut, (20080000), vol. 57, pages 483 - 491
    - BOBEK V. et al., "Syngeneic lymph-node-targeting model of green fluorescent protein-expressing Lewis lung carcinoma", Clin. Exp. Metastasis, (20040000), vol. 21, no. 8, doi:10.1007/s10585-004-8118-8, pages 705 - 8, XP019235796

DOI:   http://dx.doi.org/10.1007/s10585-004-8118-8
    - DEVIREN G. et al., "Detection of antigen-specific T cells on p/MHC microarrays", J. Mol. Recognit., (20070100), vol. 20, no. 1, doi:10.1002/JMR.805, pages 32 - 8, XP002667108

DOI:   http://dx.doi.org/10.1002/JMR.805
    - PETERSEN et al., "In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery", Basic & Clinical Pharm & Toxicology, (20060000), vol. 99, no. 2, doi:10.1111/j.1742-7843.2006.pto_298.x, pages 104 - 115, XP055360626

DOI:   http://dx.doi.org/10.1111/j.1742-7843.2006.pto_298.x
    - "Mouse Models of Innate Immunity: Methods and Protocols", Methods in Molecular Biology, (20130000), vol. 1031
    - "Mouse Models of Innate Immunity: Methods and Protocols", Methods in Molecular Biology, Springer Science + Business Media, LLC, (20130000), vol. 1031
    - TAUBECARLSTEN, "Action of dexamethasone in the suppression of delayed-type hypersensitivity in reconstituted SCID mice", Inflamm Res., (20000000), vol. 49, no. 10, pages 548 - 52
    - CONSTANTINESCU et al., "Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS", Br J Pharmacol., (20111000), vol. 164, no. 4, doi:10.1111/j.1476-5381.2011.01302.x, pages 1079 - 1106, XP055216575

DOI:   http://dx.doi.org/10.1111/j.1476-5381.2011.01302.x
    - MANGALAM et al., "Two discreet subsets of CD8+ T cells modulate PLP - induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice", J Autoimmun., (20120600), vol. 38, no. 4, pages 344 - 353
    - CAPLAZI et al., "Mouse models of rheumatoid arthritis", Veterinary Pathology, (20150901), vol. 52, no. 5, pages 819 - 826
    - BRAND et al., "Collagen-induced arthritis", Nature Protocols, (20070000), vol. 2, pages 1269 - 1275
    - PIETROSIMONE et al., "Collagen-induced arthritis: a model for murine autoimmune arthritis", Bio Protoc., (20151020), vol. 5, no. 20, page el626
    - TANEJA et al., J. Immunology, (20070000), vol. 56, pages 69 - 78
    - O TANEJA et al., J. Immunology, (20080000), vol. 181, pages 2869 - 2877
    - TANEJA et al., Arthritis Rheum., (20070000), vol. 56, pages 69 - 78
    - WOOLEY, J. Exp. Med., (19810000), vol. 154, pages 688 - 700
    - Arthritis Res Ther., (20120000), vol. 14, no. 6, page R237
    - RANDHAWA et al., "A review on chemical-induced inflammatory bowel disease models in rodents", Korean J Physiol Pharmacol., (20140000), vol. 18, no. 4, pages 279 - 288
    - CHASSAING et al., "Dextran sulfate sodium (DSS)-induced colitis in mice", Curr Protoc Immunol., (20140204), vol. 104
    - KIM et al., "Investigating intestinal inflammation in DSS-induced model of IBD", J Vis Exp., (20120000), vol. 60, page 3678
    - BELLE et al., "Mouse models for type 1 diabetes", Drug Discov Today Dis Models, (20090000), vol. 6, no. 2, doi:10.1016/j.ddmod.2009.03.008, pages 41 - 45, XP055045317

DOI:   http://dx.doi.org/10.1016/j.ddmod.2009.03.008
    - AILEEN JF KING, "The use of animal models in diabetes research", Br J Pharmacol., (20120600), vol. 166, no. 3, doi:10.1111/j.1476-5381.2012.01911.x, pages 877 - 894, XP055516274

DOI:   http://dx.doi.org/10.1111/j.1476-5381.2012.01911.x
    - FICKERT et al., "Characterization of animal models for primary sclerosing cholangitis (PSC", J Hepatol., (20140606), vol. 0, no. 6, pages 1290 - 1303
    - POLLHEIMERFICKERT, "Animal models in primary biliary cirrhosis and primary sclerosing cholangitis", Clin Rev Allergy Immunol., (20150604), vol. 8, no. 2, pages 207 - 17
    - GEORGIEV et al., "Characterization of time-related changes after experimental bile duct ligation", Br J Surg., (20080000), vol. 95, no. 5, pages 646 - 56
    - FICKERT et al., "A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis", Am J Path., vol. 171, no. 2, pages 525 - 536
    - FICKERT et al., "Characterization of animal models for primary sclerosing cholangitis (PSC", J Hepatol., (20140000), vol. 60, no. 6, doi:10.1016/j.jhep.2014.02.006, pages 1290 - 1303, XP029020765

DOI:   http://dx.doi.org/10.1016/j.jhep.2014.02.006
    - IBRAHIM et al., "Animal models of nonalcoholic steatohepatitis: Eat, Delete, and Inflame", Dig Dis Sci., (20160506), vol. 1, no. 5, pages 1325 - 1336
    - LAU et al., Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances, (20170124), vol. 1, no. 1, pages 36 - 44
    - KLEINER et al., "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, (20050604), vol. 1, no. 6, doi:10.1002/hep.20701, pages 1313 - 1321, XP055123202

DOI:   http://dx.doi.org/10.1002/hep.20701
    - GUDJONSSON et al., "Mouse models of psoriasis", J Invest Derm., (20070000), vol. 127, doi:10.1038/sj.jid.5700807, pages 1292 - 1308, XP002692852

DOI:   http://dx.doi.org/10.1038/sj.jid.5700807
    - VAN DER FITS et al., "Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis", J. Immunol., (20090501), vol. 182, no. 9, doi:10.4049/jimmunol.0802999, pages 5836 - 45, XP055376245

DOI:   http://dx.doi.org/10.4049/jimmunol.0802999
    - TSCHOP et al., "A guide to analysis of mouse energy metabolism", Nat. Methods, (20120000), vol. 9, no. 1, pages 57 - 63
    - AYALA et al., "Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice", Disease Models and Mechanisms, (20100000), vol. 3, pages 525 - 534
    - SU CHUL JANG et al., Small, (20170000), vol. 11, no. 4, pages 456 - 461
    - WIKLANDER et al., J. Extracellular Vesicles, (20150000), vol. 4, page 10
    - H-I. CHOI et al., Experimental & Molecular Medicine, (20170000), vol. 49, page e330
    - MILLER et al., Nanoscale, (20140507), vol. 6, no. 9, pages 4928 - 35
    - CVJETKOVIC et al., Sci. Rep., (20160000), vol. 6, page 36338
    - ERICKSON et al., Molecular Cell, (20170119), vol. 65, no. 2, pages 361 - 370
    - LIU et al., JOURNAL OF BACTERIOLOGY, (20100600), vol. 192, no. 11, pages 2852 - 2860
    - KIESELBACHOSCARSSON, Data Brief., (20170200), vol. 10, pages 426 - 431
    - ROBERTS et al., "Targeted Metabolomics", Curr Protoc Mol Biol., (20120000), vol. 30, pages 1 - 24
    - DETTMER et al., "Mass spectrometry-based metabolomics", Mass Spectrom Rev., (20070000), vol. 26, no. 1, doi:10.1002/mas.20108, pages 51 - 78, XP002485404

DOI:   http://dx.doi.org/10.1002/mas.20108
    - A.J. MCBROOM et al., JBacteriol, vol. 188, pages 5385 - 5392
    - A. FRIAS et al., Microb Ecol., (20100000), vol. 59, pages 476 - 486
    - KIM et al., Nature Communications, (20170000), vol. 8, no. 626
    - TURJEMAN et al., PLoS One, vol. 10, no. 7, page e0130442
    - G. NORHEIM et al., PLoS ONE., vol. 10, no. 9, page e0134353
    - S. STUBBS et al., Letters in Applied Microbiology, (19990000), vol. 29, pages 31 - 36
    - Z. HOU, Scientific Reports, (20150000), vol. 5, no. 9570
    - TANEJA et al., Arthritis Rheum, (20070000), vol. 56, pages 69 - 78
    - FICKERT et al., "Characterization of animal models for primary sclerosing cholangitis (PSC", J Hepatol., (20140600), vol. 60, no. 6, doi:10.1016/j.jhep.2014.02.006, pages 1290 - 1303, XP029020765

DOI:   http://dx.doi.org/10.1016/j.jhep.2014.02.006
    - POLLHEIMERFICKERT, "Animal models in primary biliary cirrhosis and primary sclerosing cholangitis", Clin Rev Allergy Immunol., (20150600), vol. 48, no. 2-3, pages 207 - 17
    - IBRAHIM et al., "Animal models of nonalcoholic steatohepatitis: Eat, Delete, and Inflame", Dig Dis Sci., (20160500), vol. 61, no. 5, doi:10.1007/s10620-015-3977-1, pages 1325 - 1336, XP035905925

DOI:   http://dx.doi.org/10.1007/s10620-015-3977-1
    - TSCHOP et al., "A guide to analysis of mouse energy metabolism", Nat. Methods., (20120000), vol. 9, no. 1, pages 57 - 63
    - KIESELBACHOSCARSSON, Data Brief, (20170200), vol. 10, pages 426 - 431
    - SOMANSCHI et al., J Vis Exp., (20110000), vol. 48, page 2540
    - SAARELA, J. Applied Microbiology, (20050000), vol. 99, pages 1330 - 1339
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.